A novel quinoline derivative, DFIQ, sensitizes NSCLC cells to ferroptosis by promoting oxidative stress accompanied by autophagic dysfunction and mitochondrial damage

Yung-Ding Bow,Ching-Chung Ko,Wen-Tsan Chang,Sih-Yan Chou,Chun-Tzu Hung,Jau-Ling Huang,Chih-Hua Tseng,Yeh-Long Chen,Ruei-Nian Li,Chien-Chih Chiu
DOI: https://doi.org/10.1186/s12935-023-02984-w
IF: 6.429
2023-08-18
Cancer Cell International
Abstract:The development of nonapoptotic programmed cell death inducers as anticancer agents has emerged as a cancer therapy field. Ferroptosis, ferrous ion-driven programmed cell death that is induced by redox imbalance and dysfunctional reactive oxygen species (ROS) clearance, is triggered during sorafenib and PD-1/PD-L1 immunotherapy. DFIQ, a quinoline derivative, promotes apoptosis by disrupting autophagic flux and promoting ROS accumulation. Our pilot experiments suggest that DFIQ participates in ferroptosis sensitization. Thus, in this study, we aimed to reveal the mechanisms of DFIQ in ferroptosis sensitization and evaluate the clinical potential of DFIQ.
oncology
What problem does this paper attempt to address?